The U.S. Food and Drug Administration (FDA) has announced it has completed its comprehensive, multi-year review of Bovaer® (3-NOP), and determined the product meets safety and efficacy requirements for use in lactating dairy cattle. This paves the way for dsm-firmenich’s strategic partner Elanco Animal Health Incorporated to launch Bovaer® in the US market.

See more here